Biologics Vancouver biotech firm’s ‘3D bio-printing’ to create human tissue for transplant needs byJosh SandbergFebruary 8, 2017
Biologics SpinalCyte, LLC Announces Final Results From Phase II Animal Trials Using Human Dermal Fibroblast Transplantation for Intervertebral Disc Degeneration byJosh SandbergApril 20, 2016
